Clinical meaning
The therapeutic window (therapeutic index/TI) is the range between the minimum effective concentration (MEC — lowest drug concentration that produces the desired therapeutic effect) and the minimum toxic concentration (MTC — lowest concentration that produces toxic effects). Drugs with a NARROW therapeutic index (NTI) have a small margin between therapeutic and toxic doses — requiring precise dosing, therapeutic drug monitoring (TDM), and close clinical monitoring. Examples: warfarin, lithium, digoxin, phenytoin, theophylline, aminoglycosides, vancomycin, cyclosporine, carbamazepine, valproic acid. The therapeutic index is quantified as TI = TD₅₀/ED₅₀ (toxic dose in 50% of population / effective dose in 50% of population); higher TI = wider safety margin. Potency vs. Efficacy: POTENCY refers to the amount of drug needed to produce an effect — a more potent drug achieves the same effect at a LOWER dose (leftward shift on dose-response curve); this relates to receptor binding affinity. EFFICACY (Emax) refers to the MAXIMUM effect a drug can produce regardless of dose — a more efficacious drug achieves a higher ceiling of therapeutic effect. Example: hydromorphone is more POTENT than morphine (achieves analgesia at lower mg dose) but both have similar EFFICACY (maximum achievable pain relief). Clinically, EFFICACY matters more than potency — a highly potent drug with low efficacy is less useful than a less potent drug with high efficacy. Dose-response relationships: ED₅₀ (effective dose in 50% of subjects — lower ED₅₀ = more potent), Emax (maximum effect — higher Emax = more efficacious), graded dose-response curve (response magnitude vs. drug concentration), and quantal dose-response curve (percentage of population responding vs. dose).